357927-50-5
357927-50-5
Chemical Structure
2-Bromo-4-fluoropyridine
- CAS No.: 357927-50-5
- Formula:C5H3BrFN
- Molecular Weight:175.99
IUPAC Name: 2-bromo-4-fluoropyridine
InChIKey: AIEATTRZKVGMBO-UHFFFAOYSA-N
SMILES: FC1=CC(Br)=NC=C1
Biological Activity: 2-Bromo-4-fluoropyridine is a halogenated pyridine organic synthesis building block that can be used as an intermediate in organic synthesis-related research[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2-Bromo-4-fluoropyridine | 99.98% | 2-Bromo-4-fluoropyridine is a halogenated pyridine organic synthesis building block that can be used as an intermediate in organic synthesis-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.90
HY-327482-Bromo-5-fluoropyridine -
Similarity Score 0.89
HY-327424-Bromo-2-fluoropyridine -
Similarity Score 0.85
HY-W0083982-Bromo-4-iodopyridine -
Similarity Score 0.85
HY-W0031292-Bromo-4-chloropyridine -
Similarity Score 0.84
HY-W0051182-Amino-4-fluoropyridine -
Similarity Score 0.84
HY-W0075792-Bromo-4-methylpyridine -
Similarity Score 0.81
HY-327465-Bromo-2-fluoropyridine -
Similarity Score 0.81
HY-410002-Amino-4-bromopyridine -
Similarity Score 0.80
HY-650364-Bromo-2-hydroxypyridine -
Explore the MedChemAI to find more analogs
References
- [1]. Zhang N, et al. Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment. Journal of medicinal chemistry. 2024 Apr 11;67(7):5617-5641. [Content Brief]
- [2]. Czestkowski W, et al. Structure-Based Discovery of High-Affinity Small Molecule Ligands and Development of Tool Probes to Study the Role of Chitinase-3-Like Protein 1. Journal of medicinal chemistry. 2024 Mar 14;67(5):3959-3985. [Content Brief]
- [3]. Pemberton N, et al. Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR. ACS medicinal chemistry letters. 2024 May 09;15(5):583-589.
